CONTEXT THERAPEUTICS INC
CNTX·21077P108·US·Common Stock·Healthcare - Biotechnology-13D/G
CNTX (CONTEXT THERAPEUTICS INC) is held by 35 institutional investors as of Q1 2026. Largest holders: FRANKLIN RESOURCES INC ($10M), VANGUARD CAPITAL MANAGEMENT LLC ($9M), MARSHALL WACE, LLP ($7.7M). Net institutional sentiment: Bullish.
35
Holders
Avg rating(7 Elite)
$46.7M
Total Value
68% (40)
Fund Consensus
25 buying - 12 selling
Who's Trading
ActivistGPGreat Point Partners, LLC2.4%May 15, 2026
ActivistBOBlue Owl Capital Holdings LP5.5%May 14, 2026
ActivistOAOctagon Capital Advisors LP5.7%May 14, 2026
ActivistAVAvidity Partners Management LP8.7%May 12, 2026
ActivistSMSoleus Capital Master Fund, L.P.7.6%May 8, 2026
ActivistMBMPM BioImpact LLC11.6%Feb 17, 2026
ActivistDTDeep Track Capital, LP8.3%May 15, 2025
13F: Insider & Congress:
Showing 1-20 of 40
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer